R. Rampling
Impact in
Papers in
- Co-authors
- Martin J. van den Bent (5 shared papers)Thierry Gorlia (4 shared papers)Alba Ariela Brandes (3 shared papers)Roger Stupp (3 shared papers)Mario Campone (3 shared papers)Robin Grant (5 shared papers)Marc Frénay (2 shared papers)Johan M. Kros (2 shared papers)
- Journals
- Clinical Oncology (5 papers)Journal of Clinical Oncology (4 papers)Annals of Oncology (4 papers)Neuro-Oncology (3 papers)British Journal of Cancer (2 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
R. Rampling
28 papers receiving 3k citations
Peers
Comparison fields: 5 of 95
- Genetics 2.1k
- Oncology 348
- Cancer Research 109
- Biomaterials 76
- Toxicology 28
Countries citing papers authored by R. Rampling
This map shows the geographic impact of R. Rampling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Rampling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Rampling more than expected).
Fields of papers citing papers by R. Rampling
This network shows the impact of papers produced by R. Rampling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Rampling. The network helps show where R. Rampling may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Rampling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 807 | |
| 2 | 2009 | 477 | |
| 3 | 2001 | 334 | |
| 4 | 2010 | 206 | |
| 5 | 2008 | 192 | |
| 6 | 2002 | 184 | |
| 7 | 2012 | 172 | |
| 8 | 2016 | 140 | |
| 9 | 2008 | 106 | |
| 10 | 2011 | 82 | |
| 11 | 2012 | 53 | |
| 12 | 2013 | 44 | |
| 13 | 1997 | 41 | |
| 14 | 2011 | 38 | |
| 15 | 1997 | 35 | |
| 16 | 2003 | 31 | |
| 17 | 2011 | 29 | |
| 18 | 2013 | 27 | |
| 19 | 2002 | 25 | |
| 20 | 2012 | 19 |
About R. Rampling
R. Rampling is a scholar working on Genetics, Oncology, Cancer Research, Radiology, Nuclear Medicine and Imaging and Toxicology, having authored 30 papers that have together received 3.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (18 papers), Cancer survivorship and care (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), Radiopharmaceutical Chemistry and Applications (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Management of metastatic bone disease (1 paper). The work is most often cited by research in Genetics (2.1k citations), Oncology (348 citations), Cancer Research (109 citations), Biomaterials (76 citations) and Toxicology (28 citations). R. Rampling has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Martin J. van den Bent, Thierry Gorlia, Alba Ariela Brandes, Roger Stupp, Mario Campone, Robin Grant, Marc Frénay, Johan M. Kros, Paul M. Clément and Denis A. Lacombe. Their work appears in journals such as Clinical Oncology, Journal of Clinical Oncology, Annals of Oncology, Neuro-Oncology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.